Defence Therapeutics Inc. Stock OTC Markets
Stocks
DTCFF
CA24463V1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2694 USD | -9.87% |
|
-9.90% | -51.69% |
| 08-04 | Defence Therapeutics Inc. Announces Management Changes | CI |
| 08-04 | Defence Therapeutics Inc Announces CEO Changes | CI |
| Market Cap | 33.35M 23.94M 20.76M 19.43M 17.73M 2.29B 33.91M 228M 89.11M 1.14B 89.95M 87.98M 3.82B | P/E 2024 |
-2.5x | P/E 2025 | -9.9x |
|---|---|---|---|---|---|
| Enterprise Value | 33.62M 24.13M 20.92M 19.59M 17.88M 2.3B 34.19M 230M 89.84M 1.15B 90.69M 88.7M 3.85B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
66.13% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -9.87% | ||
| 1 week | -9.90% | ||
| Current month | -9.90% | ||
| 1 month | -16.71% | ||
| 3 months | -32.57% | ||
| 6 months | -39.89% | ||
| Current year | -51.69% |
| 1 week | 0.27 |  | 0.3 |
| 1 month | 0.25 | | 0.35 |
| Current year | 0.25 | | 0.56 |
| 1 year | 0.25 | | 0.78 |
| 3 years | 0.25 | | 2.5 |
| 5 years | 0.25 | | 6.41 |
| 10 years | 0.25 | | 6.41 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amie Phinney
CEO | Chief Executive Officer | - | 01/08/2026 |
Arnab De
DFI | Director of Finance/CFO | 55 | 20/12/2024 |
Maxime Parisotto
CTO | Chief Tech/Sci/R&D Officer | - | 25/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 53 | 01/08/2026 | |
| Director/Board Member | 64 | 05/01/2021 | |
| Director/Board Member | - | 27/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.87% | -9.90% | - | - | 21.75M | |
| -0.72% | +2.71% | +5.66% | +15.52% | 50.03B | |
| -0.69% | +12.66% | +487.29% | +589.53% | 44.36B | |
| +0.08% | +14.50% | +24.67% | +81.52% | 40.82B | |
| +0.76% | +4.49% | +35.57% | +9.95% | 39.83B | |
| +4.73% | +15.53% | +26.95% | +54.62% | 32.51B | |
| -0.41% | +4.57% | - | - | 16.85B | |
| +0.51% | +5.62% | +39.40% | +126.23% | 16.81B | |
| -0.20% | +3.19% | +5.18% | +18.55% | 14.05B | |
| +1.81% | +22.15% | +89.59% | +29.59% | 13.22B | |
| Average | -0.40% | +279.97% | +89.29% | +115.69% | 29.83B | |
| Weighted average by Cap. | +0.53% | +295.32% | +107.77% | +139.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -13.19M -9.47M -8.21M -7.69M -7.02M -904M -13.42M -90.15M -35.26M -452M -35.59M -34.81M -1.51B | -3.52M -2.53M -2.19M -2.05M -1.87M -241M -3.58M -24.07M -9.41M -121M -9.5M -9.29M -403M |
| Net Debt | 1.69M 1.21M 1.05M 985K 899K 116M 1.72M 11.55M 4.52M 57.94M 4.56M 4.46M 193M | 272K 195K 169K 158K 145K 18.63M 276K 1.86M 726K 9.32M 733K 717K 31.1M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | $0.2694 | -9.87% | 2,500 |
| 07/08/26 | $0.2989 | +4.07% | 9,400 |
| 06/08/26 | $0.2872 | -3.49% | 1,599 |
- Stock Market
- Stocks
- DTC Stock
- DTCFF Stock
Select your edition
All financial news and data tailored to specific country editions
